172 related articles for article (PubMed ID: 22105341)
1. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization.
Woeckel VJ; Koedam M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2012 Sep; 227(9):3258-66. PubMed ID: 22105341
[TBL] [Abstract][Full Text] [Related]
2. IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation.
Woeckel VJ; Eijken M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2012 Jun; 227(6):2668-76. PubMed ID: 21898404
[TBL] [Abstract][Full Text] [Related]
3. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
[TBL] [Abstract][Full Text] [Related]
4. 1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization.
Woeckel VJ; van der Eerden BC; Schreuders-Koedam M; Eijken M; Van Leeuwen JP
J Cell Physiol; 2013 Nov; 228(11):2167-74. PubMed ID: 23589129
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization.
Woeckel VJ; Bruedigam C; Koedam M; Chiba H; van der Eerden BC; van Leeuwen JP
Gene; 2013 Jan; 512(2):438-43. PubMed ID: 22967709
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
8. DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts.
Jo S; Yoon S; Lee SY; Kim SY; Park H; Han J; Choi SH; Han JS; Yang JH; Kim TH
Cells; 2020 Jan; 9(1):. PubMed ID: 31963554
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and gene networks in human osteoblasts.
van de Peppel J; van Leeuwen JP
Front Physiol; 2014; 5():137. PubMed ID: 24782782
[TBL] [Abstract][Full Text] [Related]
10. 2010 Young Investigator Award winner: Therapeutic aprotinin stimulates osteoblast proliferation but inhibits differentiation and bone matrix mineralization.
Schoenecker J; Mignemi N; Stutz C; Liu Q; Edwards J; Lynch C; Holt G; Schwartz H; Mencio G; Hamm H
Spine (Phila Pa 1976); 2010 Apr; 35(9):1008-16. PubMed ID: 20407341
[TBL] [Abstract][Full Text] [Related]
11. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
12. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.
Addison WN; McKee MD
Bone; 2010 Apr; 46(4):1100-7. PubMed ID: 20079473
[TBL] [Abstract][Full Text] [Related]
13. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
14. Biglycan modulates osteoblast differentiation and matrix mineralization.
Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
[TBL] [Abstract][Full Text] [Related]
15. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
16. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.
Ikeda U; Wakita D; Ohkuri T; Chamoto K; Kitamura H; Iwakura Y; Nishimura T
Immunol Lett; 2010 Nov; 134(1):7-16. PubMed ID: 20655952
[TBL] [Abstract][Full Text] [Related]
17. Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization.
Seriwatanachai D; Krishnamra N; van Leeuwen JP
J Cell Biochem; 2009 Jul; 107(4):677-85. PubMed ID: 19365811
[TBL] [Abstract][Full Text] [Related]
18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
19. Expression of a 1,25-dihydroxyvitamin D3 membrane-associated rapid-response steroid binding protein during human tooth and bone development and biomineralization.
Mesbah M; Nemere I; Papagerakis P; Nefussi JR; Orestes-Cardoso S; Nessmann C; Berdal A
J Bone Miner Res; 2002 Sep; 17(9):1588-96. PubMed ID: 12211428
[TBL] [Abstract][Full Text] [Related]
20. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis.
Piek E; Sleumer LS; van Someren EP; Heuver L; de Haan JR; de Grijs I; Gilissen C; Hendriks JM; van Ravestein-van Os RI; Bauerschmidt S; Dechering KJ; van Zoelen EJ
Bone; 2010 Mar; 46(3):613-27. PubMed ID: 19857615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
